How Epigenetics Differs from Genetics: A Clear Guide

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction: Defining Genetics and Epigenetics

Genetics is the study of heredity at the level of the DNA sequence. It concerns itself with the nucleotide order of the four bases—adenine (A), guanine (G), cytosine (C), and thymine (T)—that constitute the genome of an organism. The discipline examines how variations in this sequence, whether single nucleotide polymorphisms (SNPs), insertions, deletions, or larger structural rearrangements, give rise to observable traits and disease susceptibility. When a geneticist asks why an organism displays a particular phenotype, the answer is sought in the primary structure of its DNA.

Epigenetics, by contrast, is the study of heritable changes in gene expression that do not involve alterations to the underlying DNA sequence. The term, coined by Conrad Waddington in 1942, originally described the "causal interactions between genes and their products which bring the phenotype into being." Modern usage is more restrictive: an epigenetic trait is a stably heritable phenotype resulting from changes in a chromosome without alterations in the DNA sequence. The key operational distinction is that epigenetic information is written in chemical modifications on the DNA itself or on the histone proteins around which DNA is wrapped, and these modifications modulate the accessibility of genes to the transcriptional machinery.

The core difference can be stated simply: genetics is the study of the content of the genetic code, while epigenetics is the study of the accessibility of that code. Two cells in the same organism contain identical DNA sequences, yet a neuron and a hepatocyte express vastly different sets of genes. That divergence is epigenetic in origin. This guide will systematically dissect the distinctions between these two intertwined but conceptually separate layers of biological information.

The Central Dogma and Genetic Variation

The central dogma of molecular biology, articulated by Francis Crick in 1957, describes the flow of genetic information: DNA is transcribed into RNA, which is translated into protein. Genetic variation perturbs this flow at the level of the template. A mutation in the coding region of a gene can change the amino acid sequence of the encoded protein, introduce a premature stop codon, or shift the reading frame. A mutation in a promoter can alter the binding affinity of transcription factors, changing the rate of transcription initiation. These are cis-acting changes: they alter the information content of the DNA molecule itself.

Genetic variation is the substrate for natural selection. It arises through errors in DNA replication, exposure to mutagens, or recombination events. Once a mutation occurs in a germline cell, it can be transmitted to offspring and become fixed in a population. The study of genetics therefore encompasses inheritance patterns, population genetics, and the mapping of genotype to phenotype through linkage and association studies.

Epigenetics: Beyond the Sequence

Epigenetic information does not change the nucleotide sequence. Instead, it modifies the physical properties of the chromatin fiber—the complex of DNA and histone proteins that packages the genome into the nucleus. A cytosine base can be methylated at the 5-position of its pyrimidine ring. Histone tails can be acetylated, methylated, phosphorylated, or ubiquitinated at specific lysine, arginine, and serine residues. These modifications alter the electrostatic interactions between DNA and histones, changing the compaction state of chromatin and thereby the accessibility of regulatory elements to transcription factors.

Crucially, epigenetic marks are maintained through cell division. When a cell divides, the DNA sequence is faithfully copied by DNA polymerases, but the epigenetic marks must be re-established on the daughter strands. This maintenance is mediated by enzymes that recognize hemimethylated DNA or histone marks on the parental nucleosomes and copy them to the newly synthesized strands. This property of self-propagation is what makes epigenetic states heritable at the cellular level, and in some cases, across generations of organisms.

The relationship between genetics and epigenetics is not one of opposition but of hierarchy. The DNA sequence provides the framework upon which epigenetic marks are deposited. A given sequence motif may be preferentially methylated or demethylated depending on the cellular context. Conversely, epigenetic marks can influence the rate at which mutations accumulate in a given region, as methylated cytosines are prone to deamination to thymine. The two layers of information are deeply intertwined, yet they are mechanistically and conceptually distinct.

The Nature of Information: Sequence vs. Marks

DNA Sequence as the Blueprint

The DNA sequence is a digital, quaternary code. Each position in the genome is occupied by one of four nucleotides, and the information content is determined solely by the identity of that nucleotide. The sequence of a gene defines the primary structure of its protein product, the timing and level of its expression, and its response to regulatory signals. The human genome contains approximately 3.2 billion base pairs, and the sequence is remarkably stable across the lifetime of an individual. With the exception of somatic mutations that accumulate in dividing cells, the sequence in a skin cell is identical to that in a brain cell.

Genetic information is digital in the sense that it is either present or absent. A gene is either wild-type or mutant. There is no intermediate state. This digital nature makes genetic information highly robust: the sequence can be faithfully copied with an error rate of approximately 1 in 10⁹ base pairs per replication cycle, thanks to the proofreading activity of DNA polymerases and the DNA mismatch repair system.

Epigenetic Marks as Regulatory Switches

Epigenetic information is analog in nature. A given genomic locus can be methylated to varying degrees. A promoter may be 30% methylated in one cell type and 85% methylated in another. Histone modifications are similarly quantitative: the level of histone H3 lysine 4 trimethylation (H3K4me3) at a promoter correlates with the rate of transcription initiation. This analog character allows for fine-tuned regulation of gene expression, with graded responses to developmental signals or environmental cues.

The primary epigenetic marks are DNA methylation and histone post-translational modifications. DNA methylation occurs predominantly at cytosine residues in CpG dinucleotides, where a methyl group is covalently attached to the 5-carbon of cytosine by DNA methyltransferases (DNMTs). In mammalian genomes, approximately 70–80% of CpG dinucleotides are methylated, but CpG islands—regions of high CpG density often found in gene promoters—are typically unmethylated. Methylation of promoter CpG islands is associated with transcriptional repression.

Histone modifications are more diverse. The N-terminal tails of histones H3 and H4 protrude from the nucleosome core and are subject to a wide array of post-translational modifications. Acetylation of lysine residues neutralizes the positive charge of the histone tail, weakening its interaction with the negatively charged DNA backbone and promoting a more open chromatin conformation. Methylation of lysine residues can be either activating or repressing, depending on the specific residue and the degree of methylation (mono-, di-, or trimethylation). For example, H3K4me3 is associated with active promoters, while H3K27me3 is associated with Polycomb-mediated repression.

The distinction between genetic and epigenetic information is therefore one of coding modality. Genetic information is stored in the sequence of nucleotides; epigenetic information is stored in the pattern of chemical modifications on those nucleotides and on the proteins that package them. Both are heritable, but they are read and written by entirely different molecular machinery.

Heritability: Stable vs. Reversible

Genetic Mutations: Permanent and Stable

Genetic mutations are, with rare exceptions, irreversible. Once a base pair is changed, it remains changed for the life of the cell and is propagated to all daughter cells. The only way to reverse a mutation is through a second, compensatory mutation that restores the original sequence—an event of vanishingly low probability. This permanence is essential for the function of the genome as a stable repository of information across generations.

Germline mutations are inherited by offspring according to Mendelian principles. A dominant mutation in one allele is sufficient to produce a phenotype; a recessive mutation requires homozygosity. The stability of genetic information across generations is the foundation of population genetics and evolutionary biology. Allele frequencies change over evolutionary time scales through the combined effects of mutation, selection, genetic drift, and gene flow.

Epigenetic Changes: Dynamic and Reversible

Epigenetic marks are inherently reversible. DNA methylation can be actively removed by the ten-eleven translocation (TET) family of enzymes, which oxidize 5-methylcytosine to 5-hydroxymethylcytosine and further oxidation products, ultimately leading to replacement with unmodified cytosine through base excision repair. Histone modifications are removed by dedicated enzymes: histone deacetylases (HDACs) remove acetyl groups, and histone demethylases remove methyl groups. This reversibility allows cells to respond dynamically to developmental cues and environmental signals.

The reversibility of epigenetic marks is most dramatically illustrated during development. After fertilization, the zygote undergoes widespread demethylation, erasing most parental epigenetic marks. This is followed by de novo methylation during implantation, establishing the epigenetic landscape of the embryo. Similarly, during gametogenesis, primordial germ cells undergo extensive epigenetic reprogramming, including the erasure of imprinted marks and their re-establishment according to the sex of the parent.

The heritability of epigenetic marks across generations of organisms is a subject of active research. Transgenerational epigenetic inheritance—the transmission of epigenetic information from parents to offspring through the germline—has been documented in plants, nematodes, and to a limited extent in mammals. However, the extent to which this occurs in humans remains controversial. The distinction between mitotic heritability (transmission from a cell to its daughter cells) and meiotic heritability (transmission through gametes to offspring) is critical. Most epigenetic marks are mitotically heritable but are erased and re-established during gametogenesis and embryogenesis. For a more detailed discussion of this topic, see Epigenetics Inherited.

Mechanisms of Epigenetic Regulation

DNA Methylation

DNA methylation is the best-characterized epigenetic modification. The reaction is catalyzed by DNA methyltransferases, which transfer a methyl group from S-adenosylmethionine (SAM) to the 5-position of cytosine. Three catalytically active DNMTs exist in mammals: DNMT1, DNMT3A, and DNMT3B. DNMT1 is the maintenance methyltransferase; it recognizes hemimethylated CpG sites during DNA replication and methylates the newly synthesized daughter strand, thereby preserving the methylation pattern. DNMT3A and DNMT3B are de novo methyltransferases that establish new methylation patterns during development.

The functional consequence of DNA methylation depends on the genomic context. Methylation of promoter CpG islands is associated with stable transcriptional repression. This repression is mediated by methyl-CpG-binding domain (MBD) proteins, such as MeCP2 and MBD1-3, which recruit histone deacetylases and other chromatin-modifying complexes. In contrast, methylation within gene bodies is often associated with active transcription and may function to suppress spurious transcription initiation from cryptic promoters.

DNA methylation can be detected using bisulfite conversion, in which unmethylated cytosines are deaminated to uracil while methylated cytosines remain unchanged. Subsequent sequencing reveals the methylation status of individual CpG sites. This technique, known as bisulfite sequencing, can be combined with whole-genome sequencing (WGBS) to generate single-base-resolution methylation maps.

Histone Modifications

Histone modifications are catalyzed by a large array of enzymes that add or remove chemical groups on specific residues of histone proteins. The core histones—H2A, H2B, H3, and H4—form the octamer around which 147 base pairs of DNA are wrapped to form the nucleosome. The N-terminal tails of these histones extend outward and are accessible to modifying enzymes.

Histone acetyltransferases (HATs) such as p300/CBP and GCN5 add acetyl groups to lysine residues, neutralizing the positive charge and promoting chromatin decondensation. Histone deacetylases (HDACs) reverse this reaction. The balance between HAT and HDAC activity determines the acetylation status of a locus and, consequently, its transcriptional activity.

Histone methylation is more complex. Histone methyltransferases (HMTs) add methyl groups to lysine and arginine residues, and histone demethylases remove them. The functional outcome depends on the specific residue and the degree of methylation. H3K4me3 is enriched at active promoters; H3K36me3 is enriched in the body of actively transcribed genes; H3K9me3 and H3K27me3 are associated with heterochromatin and Polycomb-mediated repression, respectively. The "histone code" hypothesis posits that combinations of modifications on the same or different histones constitute a code that is read by effector proteins to determine chromatin state and gene activity.

Chromatin Structure and Non-coding RNAs

Chromatin exists in two broad states: euchromatin, which is relatively decondensed and transcriptionally active, and heterochromatin, which is condensed and transcriptionally silent. Heterochromatin is further divided into constitutive heterochromatin, which is permanently silent and found at centromeres and telomeres, and facultative heterochromatin, which can be converted to euchromatin in response to developmental signals.

ATP-dependent chromatin remodeling complexes, such as SWI/SNF and ISWI, use the energy of ATP hydrolysis to slide or eject nucleosomes, altering the accessibility of DNA to transcription factors. These complexes do not covalently modify histones but instead change the positioning of nucleosomes along the DNA.

Non-coding RNAs also participate in epigenetic regulation. Long non-coding RNAs (lncRNAs) such as XIST mediate X-chromosome inactivation by recruiting Polycomb repressive complexes to the inactive X chromosome. Small interfering RNAs (siRNAs) and Piwi-interacting RNAs (piRNAs) direct DNA methylation and histone modifications to transposable elements and other repetitive sequences, maintaining their silencing. These RNA-directed mechanisms illustrate the diversity of epigenetic regulatory pathways.

The relationship between these mechanisms and genetic mutations is fundamental: epigenetic modifications do not alter the DNA sequence but rather the accessibility of that sequence to the transcriptional machinery. For a broader overview of how these processes fit into gene regulation, see Epigenetics Explained.

Phenotypic Outcomes: Same Sequence, Different Traits

Identical Twins and Epigenetic Divergence

Monozygotic twins share essentially identical DNA sequences, yet they can display striking phenotypic differences in disease susceptibility, behavior, and physical appearance. These differences arise, in part, from epigenetic divergence that accumulates over time. As twins age, their patterns of DNA methylation and histone modification become increasingly dissimilar, a phenomenon known as epigenetic drift. This drift is influenced by environmental factors such as diet, smoking, exercise, and exposure to toxins, as well as by stochastic errors in the maintenance of epigenetic marks during cell division.

The classic demonstration of this phenomenon comes from studies comparing genome-wide DNA methylation profiles in monozygotic twins. Young twins show highly similar methylation patterns, but older twins, particularly those who have lived apart for many years, show substantial differences. These differences are not random: they tend to accumulate at specific genomic regions, including CpG islands and enhancer elements. The functional consequence is differential gene expression between the twins, which can manifest as discordance for complex diseases such as autoimmune disorders, schizophrenia, and cancer.

X-Chromosome Inactivation

X-chromosome inactivation is a paradigmatic example of epigenetic regulation producing phenotypic diversity from identical sequences. In female mammals, one of the two X chromosomes is transcriptionally silenced to achieve dosage compensation with males, who have a single X chromosome. The choice of which X chromosome to inactivate is random in the epiblast, and once established, the inactive state is stably maintained through subsequent cell divisions.

The inactive X chromosome is characterized by a specific constellation of epigenetic marks: enrichment of H3K27me3, H3K9me2, and DNA methylation at promoter CpG islands; depletion of H3K4me3 and histone acetylation; and the presence of the lncRNA XIST, which coats the inactive X and recruits silencing factors. The inactive X also replicates late in S phase and is visible as the Barr body in interphase nuclei.

Because X-inactivation is random, female mammals are mosaics: approximately half of their cells express the maternal X chromosome, and half express the paternal X chromosome. This mosaicism can produce phenotypic differences between individuals with identical DNA sequences. For example, female carriers of X-linked mutations in genes such as DMD (dystrophin) or HPRT1 (hypoxanthine-guanine phosphoribosyltransferase) may show variable clinical severity depending on the pattern of X-inactivation in relevant tissues. Skewed X-inactivation, in which one X chromosome is preferentially inactivated, can result in a carrier female manifesting symptoms of an X-linked disorder.

The phenomenon of X-inactivation also underlies the phenotypic differences observed in individuals with supernumerary X chromosomes. Regardless of the number of X chromosomes present, all but one are inactivated, a process that requires the XIST gene. The extra inactive X chromosomes contribute to the epigenetic burden of the cell but do not substantially alter gene dosage.

Methods to Study Epigenetics vs. Genetics

Genomic Tools: Sequencing and Genotyping

Genetic variation is assayed by determining the nucleotide sequence of the genome. Sanger sequencing, the first-generation method, reads individual DNA fragments by chain termination and is still used for targeted analysis of specific genes. Next-generation sequencing (NGS) technologies, including Illumina sequencing-by-synthesis and Ion Torrent semiconductor sequencing, enable massively parallel sequencing of entire genomes or exomes. Whole-genome sequencing (WGS) provides complete sequence information, while whole-exome sequencing (WES) focuses on the protein-coding regions, which constitute approximately 1–2% of the human genome.

Genotyping arrays, such as SNP microarrays, interrogate hundreds of thousands to millions of known polymorphic sites in a single assay. These arrays use allele-specific hybridization or single-base extension to determine the genotype at each locus. They are widely used for genome-wide association studies (GWAS) and for clinical applications such as pharmacogenomics and ancestry inference.

The output of these methods is a genotype call: the specific alleles present at each locus. This information is digital and unambiguous, and it does not change with the cellular context or the environment.

Epigenomic Tools: Methylation and Chromatin Assays

Epigenetic marks require different analytical approaches. DNA methylation is most commonly assayed by bisulfite conversion followed by sequencing or array hybridization. In bisulfite conversion, unmethylated cytosines are deaminated to uracil, which is read as thymine during PCR amplification and sequencing. Methylated cytosines are protected from deamination and remain as cytosine. Comparing the bisulfite-treated sequence to the reference genome reveals the methylation status of each CpG site. Reduced representation bisulfite sequencing (RRBS) enriches for CpG-rich regions using restriction enzyme digestion, while whole-genome bisulfite sequencing (WGBS) provides genome-wide coverage at single-base resolution.

Histone modifications are assayed by chromatin immunoprecipitation followed by sequencing (ChIP-seq). In this technique, cells are treated with formaldehyde to cross-link proteins to DNA. The chromatin is then sheared by sonication into fragments of approximately 200–600 base pairs. An antibody specific to the histone modification of interest is used to immunoprecipitate the cross-linked chromatin. After reversing the cross-links and purifying the DNA, the enriched fragments are sequenced and mapped to the genome. The resulting peaks indicate regions enriched for the modification.

Chromatin accessibility is measured by ATAC-seq (assay for transposase-accessible chromatin using sequencing). This method uses the Tn5 transposase, which preferentially inserts sequencing adapters into open chromatin regions. After tagmentation, the DNA is purified and sequenced. Regions of open chromatin produce high read density, while closed chromatin produces few or no reads. ATAC-seq requires only 500–50,000 cells, making it suitable for rare cell populations.

The choice of method depends on the question being asked. Genetic methods reveal the sequence; epigenetic methods reveal the state of the chromatin. Both are essential for a complete understanding of gene regulation. For a comparison of how these approaches inform our understanding of regulatory elements, see Enhancers and Promoters Differ.

Common Pitfalls and Misconceptions

Epigenetics Does Not Change the DNA Sequence

The most common misconception among students is that epigenetic modifications alter the DNA sequence. They do not. DNA methylation adds a methyl group to the 5-carbon of cytosine, but the base remains cytosine. Histone modifications alter the proteins around which DNA is wrapped, but the DNA itself is unchanged. The sequence of the genome is identical in a cell with an active gene and a cell with a silenced gene; what differs is the accessibility of that gene to the transcriptional machinery.

This distinction has important practical implications. Epigenetic changes cannot be detected by DNA sequencing alone. A gene that is silenced by promoter hypermethylation has the same sequence as an active gene. Detecting the silencing requires methylation analysis or chromatin assays. Conversely, a mutation in a gene promoter can abolish transcription without any change in epigenetic marks. The two types of information are independent and must be assayed separately.

Not All Epigenetic Marks Are Inherited

A second common error is the assumption that all epigenetic marks are inherited across generations. In fact, most epigenetic marks are erased and re-established during gametogenesis and early embryogenesis. The zygote undergoes genome-wide demethylation shortly after fertilization, followed by de novo methylation at implantation. This reprogramming ensures that most parental epigenetic marks are not transmitted to offspring.

Transgenerational epigenetic inheritance—the transmission of epigenetic information through the germline to subsequent generations—has been demonstrated in model organisms such as C. elegans and Arabidopsis thaliana, where it can persist for many generations. In mammals, the evidence is more limited. A few well-characterized examples exist, such as the Agouti viable yellow allele in mice, where the methylation status of an intracisternal A particle (IAP) retrotransposon upstream of the Agouti gene determines coat color and is stochastically inherited. However, the extent to which similar mechanisms operate in humans remains unclear. For a detailed examination of this topic, see Epigenetics Inherited.

Epigenetic Changes Are Not Always Reversible

While epigenetic marks are in principle reversible, in practice they can be remarkably stable. The inactive X chromosome is maintained in a silenced state for the entire lifetime of a female mammal. Imprinted genes maintain parent-of-origin-specific expression patterns throughout development. The stability of these marks is ensured by positive feedback loops: DNA methylation recruits histone-modifying enzymes that establish repressive chromatin, which in turn recruits DNA methyltransferases that maintain methylation.

The reversibility of epigenetic marks is the basis for epigenetic therapies. Drugs that inhibit DNA methyltransferases, such as 5-azacytidine and decitabine, are used to treat myelodysplastic syndromes and acute myeloid leukemia. Histone deacetylase inhibitors, such as vorinostat and romidepsin, are used to treat cutaneous T-cell lymphoma. These drugs exploit the reversibility of epigenetic marks to reactivate silenced tumor suppressor genes. However, their effects are not permanent, and treatment must be repeated to maintain the therapeutic response.

Epigenetics Is Not Lamarckian

A related misconception is that epigenetics provides a mechanism for Lamarckian inheritance—the inheritance of acquired characteristics. While it is true that environmental factors can influence epigenetic marks, and some of these changes may be transmitted to offspring, the analogy is misleading. Epigenetic changes are not directed by the environment toward adaptive outcomes; they are stochastic and often deleterious. Moreover, most epigenetic changes are not transmitted across generations. The occasional transgenerational inheritance of an environmentally induced epigenetic change does not constitute a general mechanism for the inheritance of acquired traits.

Summary: Key Differences at a Glance

The table below summarizes the principal differences between genetics and epigenetics.

Frequently Asked Questions

How does epigenetics differ from genetics?

Genetics concerns the DNA sequence itself—the order of nucleotides that encodes genes and regulatory elements. Epigenetics concerns chemical modifications to the DNA and its associated proteins that alter gene expression without changing the sequence. Genetic changes are permanent and directly alter the information content of the genome. Epigenetic changes are reversible and modulate the accessibility of genes to the transcriptional machinery. In short, genetics determines what the genome can encode; epigenetics determines which parts of the genome are expressed in a given cell or context. For a concise overview, see Epigenetics vs Genetics.

Are epigenetic changes inherited?

Epigenetic changes are mitotically heritable: when a cell divides, the epigenetic marks on the parental DNA are copied to the daughter strands, ensuring that the daughter cells maintain the same gene expression pattern. This is how cell identity is maintained through development. Some epigenetic changes are also meiotically heritable, meaning they are transmitted through the germline to offspring. This phenomenon, known as transgenerational epigenetic inheritance, is well documented in plants and nematodes but is less common and more controversial in mammals. Most epigenetic marks are erased during gametogenesis and embryogenesis and then re-established.

Can epigenetic changes be reversed?

Yes. Unlike genetic mutations, which are essentially irreversible, epigenetic marks can be actively removed by dedicated enzymes. DNA methylation is removed by TET enzymes, which oxidize 5-methylcytosine and ultimately replace it with unmodified cytosine. Histone acetylation is removed by histone deacetylases, and histone methylation is removed by histone demethylases. This reversibility is exploited in epigenetic therapies, such as DNMT inhibitors and HDAC inhibitors, which are used to treat certain cancers. The reversibility of epigenetic marks also allows cells to respond dynamically to environmental signals.

Do epigenetic changes affect the DNA sequence?

No. Epigenetic modifications do not alter the nucleotide sequence of DNA. DNA methylation adds a methyl group to cytosine, but the base remains cytosine. Histone modifications alter the proteins associated with DNA, not the DNA itself. The sequence of a gene is identical whether it is active or silenced. This is why epigenetic changes cannot be detected by DNA sequencing alone and require specialized assays such as bisulfite sequencing or ChIP-seq.

What are examples of epigenetic modifications?

The major epigenetic modifications are DNA methylation (methylation of cytosine at CpG dinucleotides), histone post-translational modifications (acetylation, methylation, phosphorylation, ubiquitination of histone tails), and chromatin remodeling (changes in nucleosome positioning). Non-coding RNAs, such as XIST and piRNAs, also participate in epigenetic regulation by directing chromatin-modifying complexes to specific genomic regions. These modifications work together to establish and maintain distinct chromatin states.

Why are identical twins not exactly alike?

Monozygotic twins share identical DNA sequences, yet they can differ in phenotype due to epigenetic divergence. As twins age, their patterns of DNA methylation and histone modification become increasingly different, a process called epigenetic drift. This drift is influenced by environmental factors such as diet, smoking, and exercise, as well as by stochastic errors in the maintenance of epigenetic marks. Differential epigenetic states lead to differential gene expression, which can manifest as differences in disease susceptibility, behavior, and physical traits.

How do scientists study epigenetic differences?

Epigenetic differences are studied using a variety of techniques. DNA methylation is assayed by bisulfite conversion followed by sequencing or array hybridization. Histone modifications are assayed by chromatin immunoprecipitation followed by sequencing (ChIP-seq). Chromatin accessibility is measured by ATAC-seq. These methods can be applied to specific genomic regions or genome-wide, providing a comprehensive view of the epigenetic landscape. For a broader discussion of why these processes matter, see Epigenetics Important.

Key Takeaways

• Genetics studies the DNA sequence; epigenetics studies chemical modifications that regulate gene expression without changing the sequence.
• Genetic information is digital and permanent; epigenetic information is analog and reversible.
• Epigenetic marks include DNA methylation, histone modifications, and chromatin remodeling, all of which affect gene accessibility.
• Epigenetic changes are mitotically heritable but are largely erased during gametogenesis and embryogenesis; transgenerational inheritance is limited and context-dependent.
• Identical twins and X-inactivation demonstrate that identical DNA sequences can produce different phenotypes through epigenetic mechanisms.
• Genetic variation is detected by DNA sequencing; epigenetic marks are detected by bisulfite sequencing, ChIP-seq, and ATAC-seq.
• Epigenetic changes do not alter the DNA sequence and are in principle reversible, making them targets for therapeutic intervention.

Further Reading

• Ntontsi P et al. Genetics and Epigenetics in Asthma. International journal of molecular sciences. 2021. PubMed 33673725
• Vatier C, Christin-Maitre S. Epigenetic/circadian clocks and PCOS. Human reproduction (Oxford, England). 2024. PubMed 38600622
• Koninckx PR et al. Pathogenesis of endometriosis: the genetic/epigenetic theory. Fertility and sterility. 2019. PubMed 30527836
• Arnau-Soler A et al. Food Allergy Genetics and Epigenetics: A Review of Genome-Wide Association Studies. Allergy. 2025. PubMed 39698764
• Cuevas-Sierra A et al. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications. Advances in nutrition (Bethesda, Md.). 2019. PubMed 30721960
• D'Agnelli S et al. Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers. Molecular pain. 2019. PubMed 30486733

Related Clinical & Scientific Guides

• MAPK Pathway: Mechanism, Function, and Clinical Relevance
• Mammalian Cell Culture Bioreactors: A Practical Guide
• Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks